Expression of prostate-specific antigen and androgen receptor in extramammary Paget's disease and carcinoma

Clin Exp Dermatol. 2007 Jan;32(1):91-4. doi: 10.1111/j.1365-2230.2006.02304.x. Epub 2006 Nov 30.

Abstract

Prostate-specific antigen (PSA) is a kallikrein-like serine proteinase (human kallikrein 3) produced by epithelial cells of both benign and malignant prostate tissue. In this study, PSA expression was histologically examined in tissue specimens from 34 patients with extramammary Paget's disease (EPD; 31 cases) and extramammary Paget's carcinoma (EPC; three cases), but no associated prostate carcinoma. Tumour cells positive for PSA were found in 17 of the 34 cases. Based on this finding, we examined serum PSA level in the three EPC cases. A high level of serum PSA was observed in one case of EPC, which was correlated with disease progression. Because some reports suggest that 50-80% cases of EPD/EPC express androgen receptor (AR), we also examined expression of AR. Immunohistological staining showed correlation of PSA and AR in expression. These results suggest that PSA and the androgen signalling pathway may be involved in the pathogenesis of EPD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Paget Disease, Extramammary / metabolism*
  • Paget Disease, Extramammary / pathology
  • Prostate-Specific Antigen / biosynthesis*
  • Receptors, Androgen / biosynthesis*
  • Retrospective Studies

Substances

  • Receptors, Androgen
  • Prostate-Specific Antigen